Skip to main content
. 2023 Feb 1;15(2):484. doi: 10.3390/pharmaceutics15020484

Figure 3.

Figure 3

Schematic diagram of YC-mediated nanoparticles to inflammation-associated diseases [118]. Reproduced from ref. [118] with permission from the American Chemical Society, copyright 2017.